supported by the Beijing Double Class One Human Resource Office-High-Level-Jianxun Wang's Research Team Funding Project of China(1000041510155);the Research Startup Fund Program at the Beijing University of Chinese Medicine(90011451310032).
Objective:To investigate the effects and mechanisms of Xuebijing injection(XBJ)on Chimeric antigen receptor-T(CAR-T)cell function and its therapeutic potential against CAR-T therapy-associated cytokine storms(CRS).Met...